Churchill Capital Corp XI stock rose 5.7% in pre-market trading to $16.55, as traders continued to focus on the special purpose acquisition company's proposed merger with humanoid robotics developer Agility Robotics. The uptick adds to a persistent pattern of heightened investor attention that has followed the announcement of the business combination in late June.
A recent, company-specific development that investors interpreted as supportive was the filing disclosing an unsecured promissory note of up to $1.5 million provided to Churchill Sponsor XI LLC. The interest-free note is structured as a working-capital facility that matures either on completion of the planned business combination or upon liquidation. Under the terms disclosed, the sponsor may convert outstanding balances into Churchill units at $10 each, a provision market participants read as evidence the sponsor remains committed to advancing the merger.
Options market indicators also signaled continued bullish positioning. Data showed above-normal call volume on August 16, suggesting that some traders were betting on further upside heading into the current session.
The broader rationale for Churchill’s premium to the $10 trust value centers on the proposed $2.5 billion merger with Agility Robotics, a deal that would result in what is expected to be the first U.S.-listed pure-play humanoid robotics company trading under the ticker "AGLT." The transaction is designed to provide more than $620 million in gross proceeds, which the filings break down as approximately $420 million coming from Churchill’s trust account and roughly $200 million from a private investment in public equity, or PIPE, led by Foxconn. The PIPE also counts strategic participants including NVIDIA, Amazon, and SoftBank.
Regulatory progress has continued in parallel; the companies submitted a confidential Form S-4 to the Securities and Exchange Commission in mid-July. Observers cite the sponsor’s funding move, the ongoing regulatory filing progress and investor interest in humanoid robotics as factors helping keep CCXI well above its $10 trust value and driving the pre-market advance.
At the same time, market direction offered little assistance to the move. The S&P 500 and the Nasdaq were both trading near flat in pre-market activity, leaving the stock's momentum largely attributable to deal-specific developments and derivatives positioning rather than broad market trends.